Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 830.55 | 1325.00 | 2071.50 | 0.6396 | 0.4251 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1035.00 | 2071.50 | 0.4996 | 0.1816 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 830.55 | 2151.00 | 2071.50 | 1.0384 | 1.0579 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2163.00 | 2071.50 | 1.0442 | 1.0666 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 830.55 | 1721.00 | 2071.50 | 0.8308 | 0.7377 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 1250.00 | 830.55 | 1735.00 | 2071.50 | 0.8376 | 0.7484 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1928.00 | 2071.50 | 0.9307 | 0.8940 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1763.00 | 2071.50 | 0.8511 | 0.7698 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1143.00 | 2071.50 | 0.5518 | 0.2740 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1777.00 | 2071.50 | 0.8578 | 0.7804 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1921.00 | 2071.50 | 0.9274 | 0.8888 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2220.00 | 2071.50 | 1.0717 | 1.1078 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 2077.00 | 2071.50 | 1.0027 | 1.0040 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1081.00 | 2071.50 | 0.5218 | 0.2213 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2443.00 | 2071.50 | 1.1793 | 1.2665 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 830.55 | 2234.00 | 2071.50 | 1.0784 | 1.1179 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2266.00 | 2071.50 | 1.0939 | 1.1409 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 2083.00 | 2071.50 | 1.0056 | 1.0084 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 830.55 | 818.00 | 2071.50 | 0.3949 | -0.0115 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1697.00 | 2071.50 | 0.8192 | 0.7193 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 885.00 | 2071.50 | 0.4272 | 0.0493 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 830.55 | 754.00 | 2071.50 | 0.3640 | -0.0707 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 2055.00 | 2071.50 | 0.9920 | 0.9879 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2039.00 | 2071.50 | 0.9843 | 0.9762 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1064.00 | 2071.50 | 0.5136 | 0.2067 |